Scopia Capital Management L.P., 10% Owner at ACORDA THERAPEUTICS INC (ACOR), sold 252,928 shares at $18.89 ($4.8M) on 2018-10-02, disclosed to the SEC on 2018-10-04.
Open-market sale of $4.8M ACOR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.89 | 32,649 | $617K | 12.7% |
| 2 | $18.89 | 32,649 | $617K | 12.7% |
| 3 | $19.48 | 56,289 | $1.1M | 22.6% |
| 4 | $19.48 | 56,289 | $1.1M | 22.6% |
| 5 | $18.89 | 37,526 | $709K | 14.6% |
| 6 | $18.89 | 37,526 |
| $709K |
| 14.6% |
| Total | $19.15 avg | 252,928 | $4.8M | 100% |
| Filing → |
| ITRI | SELL | 2019-05-03 | $7.4M | — | Filing → |
| ITRI | SELL | 2019-05-01 | $4.4M | — | Filing → |
| ITRI | SELL | 2019-04-22 | $1.4M | — | Filing → |